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Gaulden reported a novel and unexpected mitomycin C
(MMC) effect, namely a pronounced retardation of very late
prophase and loss of chromosome orientation in neuroblasts
of the grasshopper Chortophaga viridifasciate. Because this
effect may be due to interactions of MMC with non-DNA
targets, MMC was tested for its interaction with porcine brain
tubulin assembly in vitro and for the induction of chromo-
somal malsegregation in the diploid yeast Saccharomyces
cerevisiae strain D61.M. A reversible dose-dependent
inhibition of tubulin assembly was observed. Since no
biological activation system was present in the incubation
mixture this inhibition seems to result from an interaction
of unactivated MMC with the assembly process. The possible
chemical activation of MMC by reduction with 1,4-dithio-
erythritol (DTE) was investigated by omission of this
compound during isolation and polymerization of tubulin. The
absence of DTE resulted in a strong reduction of the net
tubulin assembly. Also under these conditions MMC led to
a dose-dependent inhibition of the assembly, indicating that
the effect of MMC on tubulin assembly is independent of a
reductive chemical modification. In S.cerevisiae D61.M,
MMC did not induce chromosome loss, but induced other
genetic events (possibly mutations, deletions or mitotic
recombination) as was detected by an increase of the total
number and of the frequency of cycloheximide-resistant
colonies. This effect could be observed with and without the
addition of rat liver S9 as an exogenous activation system.
Introduction
Mitomycin C (MMC), a well known bifiinctional alkylating agent
forming cross-links as well as mono-adducts in DNA (Waring,
1968), shows a wide spectrum of genotoxic activities. It induces
gene mutations in excision repair proficient, but not in excision
repair deficient bacteria (Levin et al., 1984). The induction of
chromosome aberrations, mitotic recombination and sister-
chromatid exchanges (SCEs) have been reported (for references
see Adler, 1981). It has been shown that MMC requires biological
reductive activation to produce DNA intrastrand cross-links (Iyer
and Szybalski, 1963).
Recently, the research group of M.E.Gaulden (Ferguson et al.,
1985; Gaulden et al., 1985) reported a novel, unexpected
biological effect induced by MMC. In neuroblasts of the
grasshopper Chortophaga viridifasciata they observed a pro-
nounced retardation of very late prophase which led to loss of
chromosome orientation within the nucleus. This effect on mitosis
is reversible and is expressed as an extended duration of very
late prophase in relation to MMC concentration and time of
exposure (Gaulden et al., 1985). This reversible inhibition of
mitosis could be related to an interaction of MMC with a non-
DNA target as, for example, the spindle. We therefore included
MMC in our testing program for chemicals interacting with
mammalian tubulin assembly in vitro. At the same time the effect
of the omission of the reductive compound dithioerythritol [DTE;
used together with glycerol for the protection of the tubulin SH-
groups during the in vitro polymerization (Dustin, 1984; Roberts
and Hyams, 1979)] on the tubulin assembly in presence of MMC
was studied to exclude a possible chemical reduction of MMC
by DTE. Since MMC effects on the tubulin assembly were found,
we tested MMC also for the ability to induce chromosome loss
and/or other genetic events (mutation, mitotic recombination,
deletion) in the diploid yeast Saccharomyces cerevisiae strain
D61.M.
Materials and methods
Chemicals
Mitomycin C (MMC, CASRN 50-07-7) was obtained from Sigma (St Louis,
MO, USA), colchicine (COL, 64-86-8) from Fluka AG (Buchs, Switzerland),
bavistan (carbendazim: methyl benzimidazole-2-yl-carbamate, 10605-21-7) from
Riedel-de Haen AG (Seelze, Hanover, FRG), and dimethylsulphoxide (DMSO,
67-68-5) from Merck AG (Darmstadt, FRG).
Tubulin isolation
Porcine brain tubulin was prepared according to Williams and Lee (1982). Two
cycles of assembly and disassembly were performed for purification. Two different
tubulin preparations were used for the two assays with COL and MMC. The
final preparation contained 10.3 mg protein/ml in the preparation used for the
COL experiments and 13.6 mg protein/ml for the one used for the MMC tests.
The protein content was determined using the method of Bradford (1976). The
preparations were stored on ice overnight and used the following day for the
assembly test (tubulin was never stored for longer periods).
Tubulin assembly test
Tubulin assembly was followed photometrically by measuring the increase in
absorbency at 350 nm (Albertini el al, 1985, 1988b). Pipes buffer (100 mM;
pH 6.9) with 2 mM EGTA (ethylene glycol-O,O'-bis(2-aminoethyl)-
/V,A/,yv',W-tetraacetic acid), 1 mM MgSO4, 2 mM dithioerythritol and 4 M
glycerol were mixed in an ice bath with 5—40 nl of 100 mM Pipes buffer
containing different amounts of MMC or COL and 10 /xl of a 50 mM solution
of GTP [guanosine-5'-triphosphate (dilithium salt)] in 100 mM Pipes buffer.
Immediately before the start of the experiment the tubulin preparation was added
(250 /d in the case of MMC and 400 /i\ for the tests with COL). The final volume
of the reaction mixture was adjusted to 1.0 ml with buffer, thoroughly mixed
and poured into a cuvette placed in the temperature-controlled compartment (37°C)
of a recording spectrophotometer.
To test the effects of the omission of the reductive compound dithioerythritol,
porcine brain tubulin was isolated and tested for its polymerization capacity in
the absence of this compound.
Yeast strain
The diploid strain D61.M of S.cerevisiae has been described previously
(Zimmermann and Scheel, 1984; Zimmermann et al., 1985; Resnicka al., 1986).
This strain is heterozygous for cyhR2, leul, trp5 and ade6 on chromosome VII
(cyhR2 and leul are positioned on its left arm and ade6 on its right arm) and
homozygous for ade2-40 on chromosome XV. Ade6 and leul are located close
to the centromere. The loss of the entire chromosome VII containing the
ttp5-marker can be detected by scoring for white, cycloheximide-resistant colonies
requiring leucine.
Compounds were judged to be positive if at least two doses showed a
reproducible increase in the absolute number of the monosomic colonies and in
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Table I. Genotoxic effects of MMC
Concentration Activation"
Oig/ml)
Experiment 1
(^
5
10
20
40
80
160
0 +
5 +
10 +
20 +
40 +
80 +
160 +
Positive control: bavistan
0!
20
Experiment 2
2.5
5
10
15
20
30
40
60
80
& +
2.5 +
5 +
10 +
15 +
20 +
30 +
40 +
60 +
80 +
Positive control: bavistan
&
10
15
Experiment 3
Oh
2.5
5.0
10.0
15.0
20.0
30.0
40.0
60.0
Positive control: bavistan
10
15
in S.cerevisiae
CFUb
(XlO6)
57.8
70.0
69.4
62.2
39.4
44.2
31.9
76.4
135.6
154.4
85.2
93.0
112.8
126.0
88.8
4.5
84.1
82.3
85.2
74.1
74.7
75.5
64.2
56.5
56.5
56.0
94.5
97.2
95.3
102.3
103.1
105.4
125.1
121.5
146.0
122.6
86.7
41.3
14.8
82.2
87.9
83.7
81.3
76.5
71.1
70.8
64.5
52.0
86.4
48.0
11.6
D61.M
Survival
(%)
100
121
120
108
68
77
55
100
178
202
112
122
148
165
100
8
100
98
101
88
89
90
76
67
67
66
100
103
101
108
109
112
132
129
154
130
100
48
17
100
107
101
98
92
86
86
78
63
100
56
13
No. of resistant
colonies0
4302"
10154"
11408k
26148k
26520"
26852"
26996"
4952"
6620"
11894"
11372"
22235"
23308"
24275"
4249"
917'
1329"
1551"
1865"
2400"
2919"
3333"
2614™
3289™
3407m
3472m
1421"
1427"
1405"
1633"
1788"
2292"
2818"
3582"
2912™
3061™
1102"
2812"
3760'
428™
626™
849™
1114™
1375™
1627™
1848™
2628™
3212™
402™
1884"
902"
Frequency"1
(XlO"5)
49.6
96.7
109.6
280.3
448.7
405.0
564.2
43.2
32.5
51.4
88.9
159.4
137.8
128.4
31.9
41.1
63.2
75.4
87.6
129.6
156.3
176.6
271.4
388.1
402.0
413.3
60.2
58.7
59.0
63.9
69.4
86.9
90.1
117.9
132.9
166.5
50.8
45.4
50.8
34.7
47.5
67.6
91.4
119.8
152.6
174.0
271.6
411.8
31.0
26.2
51.8
Resistant
whitee
9"
10"
12"
26"
42"
61"
74"
25"
14"
13"
20"
17"
42"
39"
2"
208'
7P
10P
12P
6P
17P
18P
17°
22°
20°
23°
7P
IIP
8P
6P
16"
12P
18P
12P
7°
12°
5P-q
67"
209'
7k.q
18"
22"
18"
27"
28"
28"
51"
62"
13"
62"
94"
leu~f
3
2
0
1
0
4
4
5
3
2
2
1
0
2
1
204
5
4
6
1
5
4
3
2
3
2
3
8
6
6
7
5
8
4
1
3
4
53
177
4
8
11
5
6
4
4
7
6
5
59
92
Chromosomal
mal segregation8
(XlO"6)
0.35
0.18
-
0.11
-
0.49
0.91
0.43
0.15
0.08
0.15
0.07
-
0.07
0.08
91.47
1.19
0.97
1.41
0.27
1.34
1.06
1.56
1.19
1.77
1.20
0.63
1.65
1.26
1.17
1.36
0.95
1.28
0.66
0.23
0.82
1.15
8.62
23.92
0.40
0.60
0.87
0.41
0.52
0.38
0.38
0.78
0.85
0.38
8.21
53.10
aActivation ( - : without S9; +: with S9).
bCFU: colony forming units per ml.
Total number of cycloheximide-resistant colonies plated on five plates (red
and white colonies).
dFrequency of cycloheximide-resistant colonies per 105 survivors.
cWhite: Total number of white, cycloheximide-resistant colonies on five
plates.
Leu~: Total number of white, cycloheximide-resistant, leucine-dependent
colonies on five plates.
gFrequency of white, leucine auxotrophic cycloheximide-resistant colonies.
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"Solvent control (H2O).
'Solvent control (DMSO).
"Volume plated per plate: 30 /*1 undiluted.
'Volume plated per plate: 100 pil undiluted.
""Volume plated per plate: 30 p\ of a 10"' dilution.
"Volume plated per plate: 50 p\ of a 10"' dilution.
"Volume plated per plate: 60 1^ of a 10"' dilution.
PVolume plated per plate: 100 /i\ of a 10"' dilution.
'Only four instead of five plates were counted.
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Fig. 1. (A) Tubulin assembly test with 3.4 mg/ml porcine brain tubulin and different concentrations of MMC. Incubation at 37°C. (B) Second cycle of
tubulin assembly. At the end of the first cycle shown in (A) the cuvettes were incubated for 30 min at 0°C and then the second cycle was run by an
incubation at 37°C without further additions. (C) Tubulin assembly test with 4.1 mg/ml porcine brain tubulin and different concentrations of COL. Incubation
at 37 °C.
the frequency of malsegregants per 106 survivors. The induced frequencies must
be >2 x 10"6. Other genetic events, such as gene mutation, mitotic
recombination or deletion, lead to red cycloheximide-resistant colonies, as well
as to white, cycloheximide-resistant, leucine prototrophic colonies (in case of at
least two simultaneous events). The results of the total number of resistant colonies
(red and white colonies) were designated as positive if there was a dose-related
increase of the absolute number besides an increase in the frequency of > 2-fold
(>50% survivors) or > 3-fold (<50% survivors) compared to the control
(Albertini et al., 1988a).
Treatment procedures
Cells were grown in a liquid medium (YEP medium) containing yeast extract
(1%), peptone (2%) and glucose (2%) to a cell density of 3 - 5 x 107 cells/ml.
Before treatment, the cultures were diluted 20-fold with fresh medium and allowed
to grow for 3—4 h. The initial titre at the beginning of the treatment was
- 1 x 106 cells/ml. The cells were incubated during 18 h (overnight) at 28°C
in a water bath with a orbital shaker together with the test compound. MMC
was dissolved in H2O and bavistan in DMSO [the amount of DMSO in the
final incubation medium was <2% (v/v) (Zimmermann and Scheel, 1984)]. The
total volume of the treatment mixture was 5 ml. Volumes of 100 /il or 30 pi
of the undiluted suspension or 30, 50, 60 or 100 /il of a 10"' dilution were plated
(as indicated in Table I), without washing, directly on solid complete medium
with cycloheximide (2 mg/1) to score either for cycloheximide-resistant colonies
(red and white) and/or for white, cycloheximide-resistant colonies, which were
subsequently tested for leucine auxotrophy by streaking out on synthetic medium
without leucine. White, cycloheximide-resistant colonies not growing on these
plates were classified as leu ~. The red colonies indicate the induction of mitotic
recombination between the centromere and the cyh locus or other mutational events.
The number of surviving cells were determined by plating 0.1 ml aliquots from
appropriate dilutions onto solid complete medium (YEP-medium).
Rat liver S9
Rat liver S9 was prepared according to Ames et al. (1975). Liver enzymes were
induced with phenobarbital (Siegfried, Switzerland; diluted in pyrogen-free aqua
bidest.) and j3-naphthoflavone (Serva, Heidelberg, FRG; suspended in corn oil)
following the method of Matsushima et al. (1976, 1980). The protein content,
determined according to Lowry et al. (1951), was 37.2 mg/ml. The preparation
was shown to be sterile. For experiments including an exogenous activation system,
1 ml S9 mix containing 30% (v/v) S9 (Ames et al, 1975) was added to a 4 ml
treatment mixture before the beginning of the incubation.
Colony counting
After 3 - 5 days (for survivors) and 7-10 days (for resistants) the colonies were
marked and counted with a Gallenkamp colony counter (Gallenkamp,
Loughborough, UK). In Experiment 1 for plates with >400 colonies, characteristic
sectors of 1/2 to 1/12, containing between 200 and 400 colonies, were chosen
and counted manually. In experiments 2 and 3 the whole surface of the plates
were counted.
Results
Tubulin assembly test
MMC in a dose range from 60 to 210 fiM inhibited the tubulin
assembly in vitro (Figure 1A). The concentration for a 50%
inhibition of the assembly was —150 iiM. After 30 min at 0°C
the absorbency again reached the initial value independently of
the addition of MMC. During the following second cycle MMC
inhibited tubulin assembly to the same extent as in the first cycle
(Figure IB). There were only two differences between the first
and the second cycle: (a) in the second cycle the curves started
out at slightly higher values and (b) the lag-phase before the start
of the assembly was longer (7 min compared to 4 min in the
first cycle). But finally for the different amounts of MMC the
same plateau levels were reached as in the first cycle.
The complete disassembly and the fact that the curves of the
second cycle resemble those of the first one show that the
inhibition of the tubulin assembly by MMC is reversible.
COL was used as a positive control. As expected, tubulin
assembly was inhibited by COL in the concentration range from.
6 to 30 uM, the concentration for a 50% inhibition being 12 /iM
(Figure 1C). This concentration is < 10 times smaller than the
respective value for MMC.
MMC can be activated by reductive processes. Therefore
tubulin isolated without addition of dithioerythritol (DTE), was
prepared and assayed in vitro for effects of MMC in the absence
of this reducing agent. The amount of isolated tubulin was only
— 14% compared to the standard procedure with the addition
of DTE. Accordingly, the GTP-dependent polymerization process
was also much weaker than in the normal in vitro assembly assay.
The plateau value reached without addition of MMC was only
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Fig. 2. (A) Tubulin assembly test with 3.2 mg/ml porcine brain tubulin without addition of dithioerythritol in the presence of different concentrations of
MMC. Incubation at 37°C. (B) Second cycle of tubulin assembly without addition of dithioerythritol. At the end of the first cycle shown in (A) the cuvettes
were incubated for 30 min at 0°C and then the second cycle was run by a incubation at 37°C without further additions.
0.12 U at 350 run which is —50% of the maximum absorbency
normally obtained (Figure 2). Nevertheless, a dose-dependent
reversible inhibition of tubulin polymerization was observed by
the addition of MMC (Figure 2A and B). The 50% inhibition
concentration was only slightly higher than in presence of DTE
(180 /iM). The lag time for the second cycle was again longer
compared to the first in vitro assembly.
Genotoxic effects in yeast
In three independent experiments MMC was tested with and
without rat liver S9-mix up to a dose of 160 jtg/ml (corresponding
to 0.48 raM; Table I, Experiment 1). Only without addition of
S9 MMC showed cytotoxic effects [with 40 ng MMC per ml
(corresponding to 0.12 mM) 70—80% survivors]. The frequency
of the total number of cycloheximide resistant colonies (red and
white coloured) increased in a dose-related manner. The effect
was stronger without S9 than with S9. With 40 /tg MMC/ml
without S9 the increase was between 6- and 9-fold compared to
the concurrent control, whereas with S9 only a 2- and 4-fold
increase was observed. The maximum increase was obtained in
the third experiment with 60 /tg MMC/ml where a factor of 12
was obtained. The absolute number of white, cycloheximide-
resistant colonies also increased dose-dependently in the absence
of the activation system, but almost all colonies turned out to
be leucine-independent. Therefore they are not the result of
chromosomal malsegregation. Correspondingly the frequency of
the white, leucin-auxotrophic resistants did not show a dose-
dependent increase. An additional test for trypotophan auxotrophy
showed that all white colonies were tryptophan prototrophs (data
not shown).
These results clearly show that MMC does not induce mitotic
chromosomal malsegregation, in the dose range tested, but
strongly induces mitotic recombination and/or other genotoxic
effects (mutations, deletions).
With 10-20 /ig/ml bavistan, used as a positive control for the
induction of chromosomal malsegregation (Table I), frequencies
for chromosomal malsegregation were obtained in the range
usually found (Zimmermann and Scheel, 1984; Mayer and Goin,
1987; Albertini etai, 1985, 1988a). More than 90% of the
white, cycloheximide-resistant colonies induced by the bavistan
treatment were leucine-dependent indicating malsegregation of
chromosomes (Table I).
Discussion
MMC requires activation before it can function as an alkylating
agent. The activation process is a NADPH-dependent enzymatic
reduction of MMC to its hydroquinone derivative by one of the
enzymes belonging to the group of quinone reductases, also
referred to as diaphorases. This facilitates a protonation of the
aziridine nitrogen thereby promoting intracellular alkylation of
nucleophilic centres (Moore, 1977). An additional mechanism
for the activity of MMC was found in the formation of oxygen
radicals (Pristos and Sartorelli, 1986). Attack by the activated
agent on the vital cellular moiety, e.g. DNA, is expected to result
in cytotoxicity or mutagenicity; conversely, reaction with non-
critical moieties or water will lead to detoxification (Goldberg,
1965). The enzymes (NADPH-cytochrome C reductase, xanthine
oxidase) necessary for the activation are ubiquitous among
prokaryotic and eukaryotic systems. It was shown by Iyer and
Szybalski (1964) that cross-linking of DNA occurs after activation
of MMC by cell lysates, e.g. from Sarcina lutea, Baccilus subtilis
or Escherichia coli (for review see Stevens etal, 1965).
Therefore, neither bacterial nor yeast mutagenicity test systems
need an exogenous metabolizing system for the activation of
MMC, as was also found with our yeast experiments. On the
contrary, the addition of S9-mix reduced the genotoxic activity
of MMC in 5. cerevisiae D61 .M an effect which was also found
with bacteria (SOS Chromotest; Quillardet et al, 1985).
In the in vitro porcine brain tubulin assembly assay no
biological reducing systems (cell lysates, cytochrome C reductase,
xanthine oxidase; Pristos and Sartorelli, 1986) were used.
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Inhibition of tubulin assembly by MMC
Initially, we intended to use MMC as a negative control. But
unexpectedly MMC inhibited the tubulin assembly in vitro in a
manner comparable to our positive control, colchicine, admittedly
in a higher dose range; the 50% inhibition concentrations were
15 nM (Dustin, 1984; Albertini et al., 1988b) and 150 jtM for
colchicine and MMC, respectively. The omission of the reductive
compound DTE in the in vitro tubulin assembly was without effect
on the inhibitory activity of MMC. These data show that
unactivated, i.e. unreduced MMC, is able to interact with tubulin
assembly in vitro.
In vivo, the reversible inhibition of mitosis in very late prophase
(Ferguson et al., 1985; Gaulden et al., 1985) corresponding to
the reversible inhibition of tubulin assembly in vitro might result
either from an interaction of unactivated MMC with the mitotic
spindle or from an interaction of MMC with the nuclear envelope
leading to a disconnection of centromeres with the nuclear
envelope. The reversibility of this in vivo effect might be related
to the reductive metabolism of MMC resulting in a time-
dependent decrease in the concentration of unactivated MMC.
The yeast data of our study can be summarized as follows:
MMC induces red and white cycloheximide-resistant colonies
[as a result of mutation, mitotic recombination or partial
chromosome loss (deletion)], but does not induce chromosomal
malsegregation, which would result in an increase of the number
of white, cycloheximide resistants showing leucine auxotrophy.
Bavistan, used as positive control for the induction of
chromosomal malsegregation, on the other hand specifically
induced white, leucine auxotrophic, cycloheximide-resistant
colonies, but did not increase the frequency of the cycloheximide-
resistant colonies. The results with bavistan are in agreement with
previously published data (Zimmermann and Scheel, 1984;
Albertini etai, 1985, 1988a; Mayer and Goin, 1987).
The MMC effect is not dependent on the presence of an
extracellular activation system. It remains to be elucidated
whether reductive processes in the yeast cytoplasma can lead to
activated, i.e. reduced, forms of MMC which subsequently react
with DNA thus inducing recombinational and/or mutational
events.
The fact that MMC does not induce chromosome loss in yeast
S.cerevisiae D61.M may be explained by different hypotheses:
(i) MMC does not interact with yeast tubulin at all due to
differences between yeast and porcine brain tubulin.
(ii) The concentration of intranuclear MMC which is not metab-
olized by reductive processes is too small for the induction of
chromosome loss by binding to tubulin, whereas MMC possibly
after reductive activation readily interacts with DNA thus leading
to different mutational events as detected by the induction of
cycloheximide-resistant colonies. The question remains to be
answered whether MMC is reduced so effectively inside the yeast
cell that not enough of the unmetabolized compound is available
for an interaction with tubulin.
The yeast data reported in this paper are in disagreement with
those published by Parry (1977). This author found a dose-
dependent increase of monosomic colonies in a dose range of
5—40 /ig MMC per ml with S.cerevisiae D6. The frequency of
monosomic colonies/106 survivors raised to 400 monosomic
colonies per 106 survivors with 10 fig MMC/ml. Unfortunately
it is not clear whether or not the white, cyhR colonies were
tested for their leucine requirement. In our study we found that
almost all white, cycloheximide-resistant colonies are leucine-
independent (Table I). The putative aneuploidy induction
observed by Parry (1977) therefore seems rather to be due to
a high frequency of recombination, mutation or deletion induced
by MMC.
In Drosophila, two reports indicate the induction of complete
chromosome loss by MMC. One in male germ cells (Graf and
Wurgler, 1982) and one in immature oocytes (Walker and
Williamson, 1975). Unfortunately, the mechanism(s) leading to
the elimination of the chromosome from the Drosophila germ
cells is (are) not known. Also several other papers deal with the
induction of aneuploidy by MMC via non-disjunction in various
test systems. Two assays for chromosome gain in Drosophila
and one assay with mammalian cells in culture (hyperploidy in
human peripheral blood lymphocytes) are negative, whereas all
other data (with Aspergillus, Neurospora, Saccharomyces,
mammalian somatic cells and mammalian male germ cells) are
inconclusive (Dellarco et al., 1986).
With the data available at present it remains open whether
MMC actually induces chromosomal malsegregation. Chromo-
some loss as a consequence of the chromosome breaking activity
by activated MMC as well as malsegregation of chromosomes
as a consequence of the interaction between unactivated MMC
and the tubulin in the mitotic spindle seem to be possible.
Further studies, especially with mammalian cells, are needed to
establish the potential aneuploidy inducing capacity of MMC and
if induction occurs to distinguish between the two possible
mechanisms.
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